Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Indian (NIFTY) Pharma Industry Analysis

UpdatedMay 22, 2026
DataAggregated Company Financials
Companies183
  • 7D1.5%
  • 3M11.6%
  • 1Y11.3%
  • YTD9.8%

Over the last 7 days, the Pharma industry has risen 1.5%, driven by gains from Gland Pharma of 25%. In the last 12 months, the industry was up 11%. Earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Indian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 22 May 2026₹22.4t₹4.5t₹635.9b29.3x35.3x5x
Sun, 19 Apr 2026₹20.5t₹4.3t₹621.0b28x33x4.7x
Tue, 17 Mar 2026₹20.3t₹4.3t₹621.2b25.5x32.7x4.7x
Thu, 12 Feb 2026₹20.2t₹4.3t₹616.4b28.3x32.7x4.7x
Sat, 10 Jan 2026₹20.3t₹4.2t₹613.3b28.5x33.1x4.8x
Mon, 08 Dec 2025₹20.6t₹4.2t₹612.9b29x33.6x4.9x
Wed, 05 Nov 2025₹20.3t₹4.1t₹596.1b30.2x34.1x5x
Fri, 03 Oct 2025₹20.0t₹4.1t₹588.1b30.6x34.1x4.9x
Sun, 31 Aug 2025₹20.0t₹4.1t₹589.1b29.6x33.9x4.9x
Tue, 29 Jul 2025₹20.9t₹4.0t₹597.0b32.5x35x5.2x
Thu, 26 Jun 2025₹20.1t₹4.0t₹595.3b32.7x33.8x5.1x
Sat, 24 May 2025₹19.8t₹4.0t₹580.2b31.8x34x4.9x
Mon, 21 Apr 2025₹19.5t₹3.9t₹559.2b28.5x34.8x5x
Wed, 19 Mar 2025₹19.1t₹3.9t₹559.4b28.7x34.1x4.9x
Fri, 14 Feb 2025₹19.3t₹3.9t₹550.6b28.8x35.1x5x
Sun, 12 Jan 2025₹20.5t₹3.8t₹527.0b33.7x38.9x5.4x
Tue, 10 Dec 2024₹20.7t₹3.8t₹526.7b36.2x39.4x5.4x
Thu, 07 Nov 2024₹21.3t₹3.8t₹508.0b39.9x41.9x5.6x
Sat, 05 Oct 2024₹21.4t₹3.7t₹492.6b41.2x43.5x5.7x
Mon, 02 Sep 2024₹21.2t₹3.7t₹492.4b39.8x43x5.7x
Wed, 31 Jul 2024₹19.5t₹3.7t₹461.3b38.2x42.3x5.3x
Fri, 28 Jun 2024₹17.4t₹3.6t₹448.3b33.6x38.8x4.9x
Sun, 26 May 2024₹17.1t₹3.5t₹443.8b33.4x38.5x4.8x
Tue, 23 Apr 2024₹16.6t₹3.5t₹418.9b33.2x39.6x4.8x
Thu, 21 Mar 2024₹16.4t₹3.5t₹418.7b31.8x39.2x4.7x
Sat, 17 Feb 2024₹16.9t₹3.5t₹418.9b33.7x40.4x4.9x
Mon, 15 Jan 2024₹15.7t₹3.4t₹395.3b35.2x39.6x4.6x
Wed, 13 Dec 2023₹14.1t₹3.4t₹395.1b31.3x35.7x4.2x
Fri, 10 Nov 2023₹13.6t₹3.3t₹388.9b30.1x35.1x4.1x
Sun, 08 Oct 2023₹13.1t₹3.3t₹369.9b30.1x35.4x4x
Tue, 05 Sep 2023₹12.9t₹3.3t₹367.0b29.8x35x3.9x
Thu, 03 Aug 2023₹12.7t₹3.2t₹345.8b29.4x36.7x4x
Sat, 01 Jul 2023₹11.7t₹3.2t₹342.4b26.4x34.3x3.7x
Mon, 29 May 2023₹10.6t₹3.1t₹339.1b27.3x31.1x3.4x
Price to Earnings Ratio

31.1x


Total Market Cap: ₹10.6tTotal Earnings: ₹339.1bTotal Revenue: ₹3.1tTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Pharma Industry Price to Earnings3Y Average 36.5x202420252026
Current Industry PE
  • Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 36.5x.
  • The industry is trading close to its 3-year average PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 23% per year over the last three years.
  • Revenues for these companies have grown 12% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Healthcare industry?

IN Market-0.16%
Healthcare1.46%
Pharma1.54%
Pharma1.54%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GLAND Gland Pharma₹2.33k24.9%
+₹76.7b		52.7%PE37.4x
ZYDUSLIFE Zydus Lifesciences₹1.04k2.7%
+₹27.4b		14.3%PE20.7x
500420 Torrent Pharmaceuticals₹4.48k1.8%
+₹26.4b		41.3%PE66.8x
ACUTAAS Acutaas Chemicals₹2.95k8.1%
+₹18.0b		152.5%PE67.8x
SPARC Sun Pharma Advanced Research₹209.7728.2%
+₹15.0b		28.5%PE4.4x

Latest News

ZYDUSLIFE
₹1,038.95
Zydus Lifesciences
7D
2.7%
1Y
14.3%
AUROPHARMA
₹1,463.50
Aurobindo Pharma
7D
-3.2%
1Y
22.3%
GLAND
₹2,334.00
Gland Pharma
7D
24.9%
1Y
52.7%
506943
₹2,196.30
J. B. Chemicals & Pharmaceuticals
7D
2.8%
1Y
29.0%
SPARC
₹209.77
Sun Pharma Advanced Research
7D
28.2%
1Y
28.5%
512529
₹246.00
Viyash Scientific
7D
9.6%
1Y
36.6%
GLENMARK
₹2,259.10
Glenmark Pharmaceuticals
7D
-2.9%
1Y
59.1%
ALKEM
₹5,404.50
Alkem Laboratories
7D
-1.5%
1Y
2.2%
500124
₹1,307.10
Dr. Reddy's Laboratories
7D
-2.2%
1Y
6.3%
CIPLA
₹1,399.20
Cipla
7D
-2.3%
1Y
-5.7%
Analysis Article • May 16

Cipla Limited Just Missed EPS By 7.0%: Here's What Analysts Think Will Happen Next

Cipla Limited ( NSE:CIPLA ) missed earnings with its latest annual results, disappointing overly-optimistic...
500660
₹2,309.80
GlaxoSmithKline Pharmaceuticals
7D
-5.3%
1Y
-23.6%
PFIZER
₹4,670.80
Pfizer
7D
-5.7%
1Y
-9.3%
500420
₹4,484.15
Torrent Pharmaceuticals
7D
1.8%
1Y
41.3%
Narrative Update • May 12

500420: New Metabolic Launches And Dividend Payouts Will Shape Balanced Outlook

Analysts have nudged their fair value estimate for Torrent Pharmaceuticals from ₹4,540.32 to ₹4,564.93, reflecting slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 22, 2026 to consider audited financial results for the year ended March 31, 2026 and a potential final dividend for 2025-26, along with enabling resolutions for possible equity fund raising, including convertible bonds or debentures and other modes (company filing).
SUNPHARMA
₹1,844.60
Sun Pharmaceutical Industries
7D
-1.8%
1Y
9.6%
Narrative Update • May 11

SUNPHARMA: Obesity Therapies And Organon Deal Prospects Will Shape Balanced Outlook

Analysts have nudged their price target for Sun Pharmaceutical Industries higher from about ₹1,959 to roughly ₹1,992, reflecting updated assumptions around revenue growth, profit margins and future P/E multiples. What's in the News Sun Pharmaceutical Industries is reported to be close to finalising a deal to acquire assets of Organon & Co. in a transaction valued at over US$12b, funded through a mix of debt from global banks and internal cash reserves, with an announcement expected soon (CNBC-TV18, M&A rumors and discussions).
ACUTAAS
₹2,951.20
Acutaas Chemicals
7D
8.1%
1Y
152.5%
Analysis Article • May 08

Acutaas Chemicals' (NSE:ACUTAAS) Earnings Are Of Questionable Quality

Acutaas Chemicals Limited ( NSE:ACUTAAS ) just reported some strong earnings, and the market reacted accordingly with a...
LAURUSLABS
₹1,343.50
Laurus Labs
7D
1.5%
1Y
126.4%